MARY WEIR: Open Payments
NPI 1861689200 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,527 in 218 payments from 34 companies in 2025. Trend: 2023 $916 · 2024 $2,204 · 2025 $3,527
Food & beverage: $3,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $521 |
| PFIZER INC. | 43 | $451 |
| Teva Pharmaceuticals USA, Inc. | 10 | $212 |
| Eisai Inc. | 5 | $194 |
| Impel Pharmaceuticals LLC | 9 | $186 |
| Genentech USA, Inc. | 9 | $182 |
| Janssen Biotech, Inc. | 8 | $157 |
| Celgene Corporation | 13 | $152 |
| Vanda Pharmaceuticals Inc. | 6 | $143 |
| ARGENX US, INC. | 15 | $142 |
Products named: NURTEC ODT, QULIPTA, AUSTEDO XR, Leqembi, TRUDHESA, Ocrevus Zunovo, UBRELVY, ZEPOSIA.
Industry payments across TX — which companies pay providers there.
